Natalia Honchar

Associate Reporter at BioPharmaTrend  


Contributing Author   in
AI & Digital   Startups & Deals   Biotech   Tools & Methods   Novel Therapeutics  

Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.

Latest articles from Natalia


7 Companies Using AI to Design Protein Degraders

7 Companies Using AI to Design Protein Degraders

Our cells function in the continuous mode of producing and degrading proteins, keeping the balance between these two processes to maintain a healthy cellular function. However, sometimes the produced proteins might be defective, accumulating and causing pathological effects. This is …

Cracking a Drug Delivery Puzzle

  
Cracking a Drug Delivery Puzzle

Drug delivery technologies often become a remedy and a solution for various drugs on their way to clinical approval. When the drug is developed, whether it is a small molecule, peptide, nucleic acid, antibody, or even the whole living cell, …

Why Scandinavia is a Life Sciences Hub to Watch

  
Why Scandinavia is a Life Sciences Hub to Watch

Scandinavian countries are known for their active innovation in the worldwide market, including pharmaceutical and biotech fields. Numerous research institutes, start-up incubators, and grant opportunities give rise to active drug development, medical device innovation, and implementation of machine learning (ML) …

Technology Meets Biology in Canada

  
Technology Meets Biology in Canada

Over the past decade, Canada emerged as a promising global location for drug discovery and biotech business, especially when it comes to applying advanced technologies, such as artificial intelligence (AI) and quantum computing in life sciences.

A Market Review of DNA-encoded Libraries Technology in Drug Discovery

  
A Market Review of DNA-encoded Libraries Technology in Drug Discovery

(Last updated: October 05, 2022)

The interest of pharma organizations in DNA-encoded chemical libraries (DEL) technology has been growing over the years, with numerous pharma organizations now having their internal screening programs using DELs or outsourcing capabilities from specialized DEL …